


The CSL Limited (ASX: CSL) share price will be one to watch on Friday.
This follows the release of an update after the market close yesterday.
What did CSL announce?
Yesterday evening, CSL provided the market with an update on its proposed acquisition of Vifor Pharma.
CSL is currently in the process of acquiring the Swiss biotech giant for US$12.3 billion (A$17.2 billion) in cash. Management expects the deal to expand its leadership across an attractive portfolio focused on renal disease and iron deficiency.
It also highlights that Vifor has a high quality pipeline and complements CSL’s existing therapeutic focus areas. These include Haematology, Thrombosis, Cardiovascular, and Transplant.
Why is the CSL share price on watch today?
The CSL share price could be one to watch today after it revealed that 74% of Vifor shares have been tendered as part of its public tender offer.
While this is short of its original 80% target, the company has decided to waive this acceptance rate condition and thus declare the offer successful.
The company commented: “CSL welcomes the strong support it has received from Vifor shareholders for the acquisition and now plans to waive the original 80% acceptance rate condition and to declare the offer successful. Following this, a tender period for subsequent acceptance of the offer will commence on 9 March 2022 and run through until 22 March 2022.”
What now?
This development means that the transaction is on track to complete as planned, pending the satisfaction of the remaining conditions.
It explained: “CSL further advises that the regulatory approval process for the acquisition is on track and CSL remains confident that the remaining conditions will be satisfied and the transaction completed by mid-2022, as previously indicated.”
The post CSL (ASX:CSL) share price on watch following Vifor Pharma acquisition update appeared first on The Motley Fool Australia.
Should you invest $1,000 in CSL right now?
Before you consider CSL, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- 5 things to watch on the ASX 200 on Friday
- 2 ASX 50 shares Morgans rates as buys
- Why did the CSL (ASX:CSL) share price go backwards in February?
- ‘A lot of headroom to grow’: Is 2022 the year ASX investors turn to ESG shares?
- Which ASX shares might be impacted by Probuild’s collapse?
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/sJcfEYk








